Massachusetts 2023-2024 Regular Session

Massachusetts Senate Bill S1252 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 1 of 1
22 SENATE DOCKET, NO. 2018 FILED ON: 1/20/2023
33 SENATE . . . . . . . . . . . . . . No. 1252
44 The Commonwealth of Massachusetts
55 _________________
66 PRESENTED BY:
77 John F. Keenan
88 _________________
99 To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
1010 Court assembled:
1111 The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
1212 An Act regarding consistent care for addiction rooted in evidence.
1313 _______________
1414 PETITION OF:
1515 NAME:DISTRICT/ADDRESS :John F. KeenanNorfolk and PlymouthRuth B. Balser12th MiddlesexJason M. LewisFifth Middlesex2/9/2023 1 of 8
1616 SENATE DOCKET, NO. 2018 FILED ON: 1/20/2023
1717 SENATE . . . . . . . . . . . . . . No. 1252
1818 By Mr. Keenan, a petition (accompanied by bill, Senate, No. 1252) of John F. Keenan, Ruth B.
1919 Balser and Jason M. Lewis for legislation relative to consistent care for addiction rooted in
2020 evidence. Mental Health, Substance Use and Recovery.
2121 [SIMILAR MATTER FILED IN PREVIOUS SESSION
2222 SEE SENATE, NO. 1296 OF 2021-2022.]
2323 The Commonwealth of Massachusetts
2424 _______________
2525 In the One Hundred and Ninety-Third General Court
2626 (2023-2024)
2727 _______________
2828 An Act regarding consistent care for addiction rooted in evidence.
2929 Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
3030 of the same, as follows:
3131 1 SECTION 1. Section 1 of chapter 127 of the General Laws, as appearing in the 2020
3232 2Official Edition, is hereby amended by striking out the definition of “Medication-assisted
3333 3treatment” and replacing it with the following definition:-
3434 4 “Medication for addiction treatment”, treatment for a substance use disorder or alcohol
3535 5use disorder that: (i) is determined to be clinically indicated by a qualified addiction specialist;
3636 6(ii) involves the use of medication that is approved by the federal Food and Drug Administration
3737 7for treatment of a substance use disorder; and (iii) is offered in accordance with a treatment plan
3838 8that is reviewed by a qualified addiction specialist at a frequency consistent with appropriate
3939 9clinical standards. “Medication for addiction treatment” is sometimes referred to as “medication-
4040 10assisted treatment”, or “MAT”. 2 of 8
4141 11 SECTION 2. Section 16 of said chapter 127 is amended by striking out in the second
4242 12paragraph, in lines 13 and 14, the words “who is committed for a term of 30 days’ imprisonment
4343 13or more.” and inserting in place thereof the following:-
4444 14 within 24 hours of admission to the facility. Regardless of whether the individual was
4545 15receiving medication for addiction treatment immediately prior to admission to the facility, the
4646 16examination shall include an assessment for treatment with medication for addiction treatment.
4747 17 SECTION 3. Said chapter 127 is further amended by striking out section 17B and
4848 18replacing it with the following:-
4949 19 Section 17B. Medication-assisted treatment for substance use conditions for state
5050 20detainees or prisoners at correctional facilities.
5151 21 (a) All correctional facilities, jails and houses of correction, in consultation with the
5252 22commissioner of public health, shall offer all medications for addiction treatment to a detained,
5353 23committed or incarcerated person, upon the recommendation of a qualified addiction specialist.
5454 24All correctional facilities, jails and houses of correction shall maintain or provide for the capacity
5555 25to possess, dispense and administer all medications for addiction treatment; provided, however,
5656 26that such facilities shall not be required to maintain or provide a medication for addiction
5757 27treatment that is not also a MassHealth covered benefit.
5858 28 (b) No detained, committed or incarcerated person shall be denied medication for
5959 29addiction treatment on the basis of a positive drug screening upon entering custody or at any time
6060 30during the incarceration, detention or commitment of the person; nor shall any detained,
6161 31committed or incarcerated person receive a disciplinary infraction for a positive drug screening.
6262 32The medication for addiction treatment of a detained, committed or incarcerated person shall not 3 of 8
6363 33be discontinued due to any disciplinary infraction. A detained, committed or incarcerated person
6464 34may request medication for addiction treatment at any time during the incarceration, detention or
6565 35commitment of such detained, committed or incarcerated person.
6666 36 (c) The commissioner and county sheriffs shall ensure that each detained, committed or
6767 37incarcerated person who was receiving medication for addiction treatment immediately
6868 38preceding incarceration, detention or commitment continues to have such treatment available as
6969 39soon as practicable, and in any event within 24 hours of admission to the facility, unless such
7070 40person voluntarily discontinues the treatment or unless a qualified addiction specialist
7171 41determines, based on individual medical need, that maintaining the same treatment is no longer
7272 42clinically indicated. Each detained, committed or incarcerated person shall receive the same dose
7373 43of the same medication that the person was receiving before incarceration, commitment or
7474 44detention, unless a qualified addiction specialist determines, based on individual medical need
7575 45and in consultation with the person, that a change in dose or medication is clinically indicated.
7676 46 (d) The commissioner and county sheriffs shall ensure that each detained, committed or
7777 47incarcerated person who was not receiving medication for addiction treatment immediately
7878 48preceding incarceration, detention or commitment, and for whom medication for addiction
7979 49treatment is clinically indicated, shall be offered such medication within 24 hours of the
8080 50assessment required by section 16. The determinations of which medication to prescribe and the
8181 51dosage shall be made based on individual medical need in consultation with the patient.
8282 52Detained, committed or incarcerated persons shall be authorized to receive the medication for as
8383 53long as clinically indicated. 4 of 8
8484 54 (e) All state and county correctional facilities shall ensure consistent and ongoing access
8585 55to a qualified addiction specialist by a detained, committed or incarcerated person.
8686 56 (f) Treatment established under this section shall include behavioral health counseling for
8787 57individuals diagnosed with substance use disorder or substance use-related needs; provided,
8888 58however, that counseling services shall be consistent with current therapeutic standards for these
8989 59therapies in a community setting and shall not be a substitute for medication for addiction
9090 60treatment. The commissioner and county sheriffs may make such treatment available by directly
9191 61engaging qualified providers of substance use services, through collaboration with other
9292 62agencies, and by utilizing volunteers from community recovery programs.
9393 63 (g) No incentives, rewards or punishments shall be used to encourage or discourage a
9494 64detained, committed or incarcerated person’s decision to receive or decline medication for
9595 65addiction treatment, or any particular such medication.
9696 66 (h) The commissioner of public health may promulgate regulations and guidelines
9797 67necessary to implement the treatment program under this section.
9898 68 SECTION 4. Section 17C of said chapter 127 is hereby amended by striking out the first
9999 69paragraph and replacing it with the following:-
100100 70 Not later than 120 days prior to the expected discharge date of a person detained,
101101 71committed or incarcerated in a state prison or county facility, or within a reasonable timeframe if
102102 72the length of incarceration, detention or commitment is less than 120 days, but in any event no
103103 73less than 30 days prior to such expected discharge date, a qualified addiction specialist shall
104104 74establish a medically appropriate re-entry treatment plan for the person. A re-entry treatment
105105 75plan may include any treatment upon discharge that the qualified addiction specialist shall 5 of 8
106106 76recommend and deem appropriate, which may include, but shall not be limited to, any
107107 77medication for addiction treatment. A re-entry treatment plan shall ensure that a detained,
108108 78committed or incarcerated person is directly connected to an appropriate provider or treatment
109109 79site in the geographic region in which the person shall reside upon release. A detained,
110110 80committed or incarcerated person upon release shall receive information regarding treatment
111111 81facilities in their area, information on available housing and employment resources, and any
112112 82other information that will assist the individual as they continue their addiction recovery. The
113113 83commissioner and county sheriffs shall further ensure that, for a person with a re-entry treatment
114114 84plan under this section, the facility shall request reinstatement or apply for MassHealth benefits
115115 85for the person at least 30 days prior to release or shall use best efforts to request such
116116 86reinstatement of or apply for MassHealth benefits or other public assistance for the person within
117117 87a reasonable timeframe if the person’s sentence, detention or commitment is less than 30 days.
118118 88Notwithstanding the foregoing, nothing in this section shall authorize a state prison or county
119119 89facility to extend a person’s sentence, detention or commitment to comply with this section. In
120120 90the event the expected discharge date of a detained, committed or incarcerated person serving a
121121 91sentence to a state prison or county facility is less than 30 days following the start date of said
122122 92detained, committed or incarcerated person’s sentence, detention or commitment, a qualified
123123 93addiction specialist shall use best efforts to establish a medically appropriate treatment plan for
124124 94the person prior to the expected discharge date.
125125 95 SECTION 5. Said chapter 127 is hereby amended by striking out section 17D and
126126 96replacing it with the following:-
127127 97 (a) Every six months, on a schedule to be established by the department of public health,
128128 98the commissioner and the administrator of each county correctional facility shall report, in a 6 of 8
129129 99format determined by the commissioner of public health, to the commissioner of public health,
130130 100the house and senate committees on ways and means, the joint committee on mental health,
131131 101substance use and recovery, the joint committee on public safety and homeland security and the
132132 102joint committee on the judiciary the following information for the prior six months: (i) at the
133133 103time of the report, the number of persons in the custody of the facility receiving each medication
134134 104for addiction treatment, in total and disaggregated by dosage; (ii) the number of persons in the
135135 105custody of the facility, in any status, who continued to receive the same medication for addiction
136136 106treatment as they received prior to incarceration, detention or commitment, by medication type;
137137 107(iii) the number of persons in the custody of the facility, in any status, who discontinued
138138 108medication for addiction treatment that they received prior to incarceration, detention or
139139 109commitment by medication type; (iv) the number of persons in the custody of the facility, in any
140140 110status, who received a different medication for addiction treatment than they received prior to
141141 111incarceration, detention or commitment, by medication type; (v) the number of persons in the
142142 112custody of the facility, in any status, who received medication for addiction treatment who did
143143 113not receive such treatment prior to incarceration, detention or commitment, by medication type;
144144 114(vi) a summary of facility practices and any changes to those practices related to medication for
145145 115addiction treatment; (vii) the number of persons who were connected to treatment after release;
146146 116(viii) the number of nonfatal and fatal overdoses in the facility; (ix) the number of nonfatal and
147147 117fatal overdoses within 1 year of release from the department of correction and each county
148148 118facility, provided, however, that the commissioner, the sheriffs, and the commissioner of public
149149 119health shall coordinate to provide such information; (x) the number of persons who received a re-
150150 120entry treatment plan under section 17C and were subsequently enrolled in MassHealth upon
151151 121discharge; provided, however, that the commissioner, the sheriffs, the commissioner of medical 7 of 8
152152 122assistance and the commissioner of public health shall coordinate to provide such information;
153153 123and (xi) any other information requested by the commissioner of public health related to the
154154 124provision of medication for addiction treatment.
155155 125 (b) Every 2 years, not later than April 30, the commissioner of public health shall prepare
156156 126a report, pursuant to section 237 of chapter 111, regarding outcomes for the treatment programs
157157 127established under sections 17B and 17C to the house and senate committees on ways and means,
158158 128the joint committee on mental health, substance use and recovery, the joint committee on public
159159 129safety and homeland security and the joint committee on the judiciary. The department of
160160 130correction and county correctional facilities shall provide, upon request from the commissioner
161161 131of public health, information necessary to prepare the report. The report shall, to the extent
162162 132possible, provide a comparison between the detained, committed and incarcerated persons who
163163 133did not receive medication for addiction treatment and those who did, reported separately for
164164 134each medication type, in order to determine the impact of the treatment programs on the
165165 135following: (i) treatment retention after release; (ii) substance use after release; (iii) rates of
166166 136recidivism; (iv) rates of nonfatal and fatal overdose; and (v) other outcome measures identified
167167 137by the commissioner of public health.
168168 138 SECTION 6. As soon as practicable, and in any event within 30 days of passage of this
169169 139legislation, all state and county correctional facilities shall assess for treatment with medication
170170 140for addiction treatment all detained, committed or incarcerated persons in their respective
171171 141institutions who have substance use-related needs but who are not currently receiving medication
172172 142for addiction treatment. Detained, committed or incarcerated persons for whom such medication
173173 143is clinically indicated shall be offered such medication within 24 hours of such assessment, and 8 of 8
174174 144such medication shall be prescribed and provided in a manner consistent with the provisions of
175175 145section 17B of chapter 127.
176176 146 SECTION 7. Section 98 of chapter 208 of the acts of 2018 is hereby repealed.